课题基金 / 基金详情

GORDON CONFERENCE ON MODIFIERS OF CARDIAC CONTRACTILITY

GORDON CONFERENCE ON MODIFIERS OF CARDIAC CONTRACTILITY
心脏收缩调节剂戈登会议
批准号:
3435593
负责人:
MARTIN MORAD
金额:
$1.0万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1986
资助国家:
美国
项目状态:
已结题
起止时间:
1986-05-01 至 1986-09-30

项目摘要

项目成果

MARTIN MORAD的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This conference will deal with mechanisms involved in modulation of cardiac contractility. A host of mechanisms and their modifications by pharmacological agents or physiological regulation will be considered. The conference will deal not only with the molecular mechanisms of Ca2+ transport across the membrane, the nature of signal transmitted information from the surface membrane to SR, the regulation of mechanism of Ca2+ release and re-uptake, the mechanism involved in modulation of myosin or phosphodiestrase isozymes, and the molecular biology of contractile proteins and membrane receptor involved in regulation of contractility, but also with a number of pharmacological agents (old and new) which are thought to modulate these processes. It is hoped that by bringing together active scientists from different disciplines we will develop some understanding of the mechanisms which regulate cardiac contractility, and get some insight into the mechanisms by which drugs alter these processes. The selection of speakers has been based on scientific excellence and proven leadership of the individual participant in the field. I have asked support only for the speakers and chairpersons of the scheduled sessions. Support for the rest of the participants (approx. 2/3 of expected participants) will come from personal funds, private resources and foreign research organizations - I hope!
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Functional implications of CPVT1-associated RyR2 mutations in human cardiomyocytes
Functional implications of CPVT1-associated RyR2 mutations in human cardiomyocytes
Functional implications of CPVT1-associated RyR2 mutations in human cardiomyocytes
Functional implications of RyR2 mutations in human cardiomyocytes
海外基金